Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mulder

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
IJTLD Open|November 17, 2025
Feasibility and acceptability of self-testing for COVID-19 in Ethiopia: a mixed-methods studyI Mitiku, S Keller, A Abera, et al.
Chembiochem : a European Journal of Chemical Biology|June 4, 2025
Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical ToolsFrancesca D'Amico, Cami M P Talavera Ormeño, Shivanganie Poeran, et al.
The New England Journal of Medicine|November 29, 1984
Virologic studies in a case of transfusion-associated AIDSJ E Groopman, S Z Salahuddin, M G Sarngadharan, et al.
Nature|February 4, 2021
Ubiquitin ligation to F-box protein targets by SCF-RBR E3-E3 super-assemblyDaniel Horn-Ghetko, David T Krist, J Rajan Prabu, et al.
Health Communication|November 21, 2014
Communication Between HIV Patients and Their Providers: A Qualitative Preference Match AnalysisBob C Mulder, Merel A A van Lelyveld, Sigrid C J M Vervoort, et al.
Neurology|May 12, 2004
Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer diseaseN S M Schoonenboom, Y A L Pijnenburg, C Mulder, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomasC A Yedema, P Kenemans, T Wobbes, et al.
Frontiers in Chemistry|March 11, 2020
Strategy for Development of Site-Specific Ubiquitin AntibodiesIla van Kruijsbergen, Monique P C Mulder, Michael Uckelmann, et al.
Transgenic Research|October 14, 2000
An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitorsM Mora, M Lazzer, G Marsicano, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2002
CSF markers related to pathogenetic mechanisms in Alzheimer's diseaseC Mulder, S N M Schoonenboom, L-O Wahlund, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
IJTLD Open|November 17, 2025
Feasibility and acceptability of self-testing for COVID-19 in Ethiopia: a mixed-methods studyI Mitiku, S Keller, A Abera, et al.
Chembiochem : a European Journal of Chemical Biology|June 4, 2025
Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical ToolsFrancesca D'Amico, Cami M P Talavera Ormeño, Shivanganie Poeran, et al.
The New England Journal of Medicine|November 29, 1984
Virologic studies in a case of transfusion-associated AIDSJ E Groopman, S Z Salahuddin, M G Sarngadharan, et al.
Nature|February 4, 2021
Ubiquitin ligation to F-box protein targets by SCF-RBR E3-E3 super-assemblyDaniel Horn-Ghetko, David T Krist, J Rajan Prabu, et al.
Health Communication|November 21, 2014
Communication Between HIV Patients and Their Providers: A Qualitative Preference Match AnalysisBob C Mulder, Merel A A van Lelyveld, Sigrid C J M Vervoort, et al.
Neurology|May 12, 2004
Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer diseaseN S M Schoonenboom, Y A L Pijnenburg, C Mulder, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomasC A Yedema, P Kenemans, T Wobbes, et al.
Frontiers in Chemistry|March 11, 2020
Strategy for Development of Site-Specific Ubiquitin AntibodiesIla van Kruijsbergen, Monique P C Mulder, Michael Uckelmann, et al.
Transgenic Research|October 14, 2000
An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitorsM Mora, M Lazzer, G Marsicano, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2002
CSF markers related to pathogenetic mechanisms in Alzheimer's diseaseC Mulder, S N M Schoonenboom, L-O Wahlund, et al.
Pageof 26